The Department of Health and Human Services (HHS) has announced new initiatives aimed at improving the prevention and treatment of tick-borne diseases, including Lyme disease. HHS Secretary Robert F. Kennedy Jr. made the announcement during a visit to New Hampshire, detailing new research funding from the National Institutes of Health and the Centers for Disease Control and Prevention (CDC) to enhance diagnostics and prevent the spread of Lyme disease and other tick-borne illnesses.
According to the Global Lyme Alliance, there are approximately 476,000 new cases of Lyme disease reported annually in the United States. While many patients recover quickly with early antibiotic treatment, estimates suggest that 10% to 20% of those treated may continue to experience symptoms. Furthermore, researchers estimate that around 2 million people in the U.S. suffer from post-treatment Lyme disease syndrome, which can lead to prolonged health issues.
Kennedy emphasized that addressing chronic Lyme symptoms is a priority for HHS, stating, "We are listening to patients, following the science, and taking action." He noted that chronic Lyme patients often face a variety of symptoms, including cardiovascular issues and autoimmune conditions.
The HHS plans to launch public-private partnerships with state health departments to develop strategies aimed at controlling tick populations, particularly in areas where they thrive, such as regions with high deer populations. The initiatives also include efforts to create individualized testing for Lyme disease biomarkers, recognizing that treatment may vary significantly among patients.
Additionally, there is ongoing congressional interest in investigating whether Lyme disease may have originated from bioweapons developed by the U.S. military in the mid-20th century, as highlighted by Rep. Chris Smith (R-NJ). A Government Accountability Office report on this matter is expected to be published later this year.
